Q3 2024 Holdings
Filed 2024-11-14 | 45 holdings | $366.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $88.3M | 741,743 | 24.1% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $82.0M | 92,593 | 22.4% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $33.7M | 532,879 | 9.2% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $15.8M | 216,519 | 4.3% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $14.9M | 190,752 | 4.1% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $13.9M | 274,424 | 3.8% |
| ELI Lilly & Co(LLY)Put | COM | 532457108 | $13.3M | 15,000 | 3.6% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $9.6M | 35,000 | 2.6% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $8.8M | 18,900 | 2.4% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $8.7M | 76,255 | 2.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $8.2M | 15,138 | 2.2% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $7.9M | 87,848 | 2.2% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $5.6M | 124,440 | 1.5% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $5.2M | 45,000 | 1.4% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $4.3M | 95,885 | 1.2% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $4.3M | 119,488 | 1.2% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $4.3M | 148,590 | 1.2% |
| Merus N V | COM | N5749R100 | $4.0M | 80,171 | 1.1% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $3.9M | 52,939 | 1.1% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $2.6M | 75,300 | 0.7% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $2.3M | 45,765 | 0.6% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $2.0M | 62,992 | 0.5% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $1.7M | 421,359 | 0.5% |
| Springworks Therapeutics Inc | COM | 85205L107 | $1.7M | 53,930 | 0.5% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $1.6M | 15,437 | 0.4% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $1.6M | 40,000 | 0.4% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $1.3M | 80,380 | 0.4% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $1.2M | 156,300 | 0.3% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $1.2M | 6,305 | 0.3% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $1.2M | 30,479 | 0.3% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $1.2M | 20,000 | 0.3% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $1.1M | 57,178 | 0.3% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $1.1M | 7,440 | 0.3% |
| Annexon Inc(ANNX) | COM | 03589W102 | $1.0M | 172,226 | 0.3% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $977.9K | 47,400 | 0.3% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $954.0K | 52,476 | 0.3% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $929.1K | 48,263 | 0.3% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $901.1K | 54,285 | 0.2% |
| Alector Inc(ALEC) | COM | 014442107 | $900.9K | 193,317 | 0.2% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $660.4K | 13,440 | 0.2% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $592.7K | 90,490 | 0.2% |
| Acelyrin Inc | COM | 00445A100 | $459.1K | 93,114 | 0.1% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $330.4K | 1,557 | 0.1% |
| Summit Therapeutics Inc(SMMT) | COM | 86627T108 | $317.8K | 14,512 | 0.1% |
| Q32 BIO Inc(QTTB) | COM | 746964105 | $209.9K | 4,705 | 0.1% |